In addition to gliomas, cartilaginous tumors experience IDH mutation [36,37,38,42], but unlike enchondromas, isolated IDH mutation is not enough to induce glioma genesis; further mutations, such as ATRX and/or TP53, are needed [41]. This evidence concerns the gene IDH2 and central nervous system cancer.